Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sucampo Pharma Inc (SCMP)

Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 849,060
  • Shares Outstanding, K 47,170
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.38
  • Price/Sales 3.39
  • Price/Cash Flow 7.47
  • Price/Book 21.18
  • Price/Earnings ttm 12.33
  • Earnings Per Share ttm 1.46
  • Most Recent Earnings $0.27 on 11/01/17
  • Next Earnings Date 03/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate 0.34
  • Number of Estimates 3
  • High Estimate 0.36
  • Low Estimate 0.32
  • Prior Year 0.68
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.85 +1.12%
on 01/24/18
18.30 -1.37%
on 01/17/18
unch (unch)
since 01/12/18
3-Month
10.10 +78.71%
on 11/16/17
18.75 -3.73%
on 01/08/18
+7.75 (+75.24%)
since 11/13/17
52-Week
9.30 +94.09%
on 04/18/17
18.75 -3.73%
on 01/08/18
+6.55 (+56.96%)
since 02/13/17

Business Summary

Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of specialized medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products - AMITIZA, its lead product, and RESCULA - and a late-stage pipeline of product candidates in clinical...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 18.14
1st Resistance Point 18.07
Last Price 18.05
1st Support Level 17.94
2nd Support Level 17.88
3rd Support Level N/A

See More

52-Week High 18.75
Last Price 18.05
Fibonacci 61.8% 15.14
Fibonacci 50% 14.02
Fibonacci 38.2% 12.91
52-Week Low 9.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar